Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the field of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and gene editing are revolutionizing the outlook for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering promise for more curative